The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis
Journal of the American Academy of Dermatology · 2023
DOI: 10.1016/j.jaad.2023.01.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2023. Verfasst von Varsha Parthasarathy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland. Hauptthemen laut MEDLINE: Prurigo, Neurodermatitis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAMS.
Abstract (Originalsprache)
BACKGROUND: Prurigo nodularis (PN) is an extremely pruritic, chronic inflammatory skin disease. Little is known about systemic inflammation in PN. OBJECTIVE: To characterize plasma inflammatory biomarkers in patients with PN and investigate the presence of disease endotypes. METHODS: In this cross-sectional study, Olink proteomic analysis was performed on plasma samples from patients with PN (n = 29) and healthy controls (n = 18). RESULTS: Patients with PN had increased levels of 8 circulating biomarkers compared to controls, including tumor necrosis factor, C-X-C Motif Chemokine Ligand 9, interleukin-12B, and tumor necrosis factor receptor superfamily member 9 (P < .05). Two PN clusters were identified in cluster 1 (n = 13) and cluster 2 (n = 16). Cluster 2 had higher levels of 25 inflammatory markers than cluster 1. Cluster 1 had a greater percentage of patients with a history of myelopathy and spinal disc disease compared with cluster 2 (69% vs 25%, P = .03). Patients in cluster 2 were more likely to have a history of atopy (38% in cluster 2 vs 8% in cluster 1, P = .09). LIMITATIONS: Small sample size precludes robust subgroup analyses. CONCLUSION: This study provides evidence of neuroimmune-biased endotypes in PN and can aid clinicians in managing patients with PN that are nonresponsive to traditional therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland.
- Eli Lilly and Company, Indianapolis, Indiana.
- Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: skwatra1@jhmi.edu.
Förderung
- NIGMS NIH HHS
- NIAMS
Zitieren
APA
Parthasarathy, V., Cravero, K., Xu, L., Deng, J., Sun, Z., Engle, S. M., Sims, J. T., Okragly, A. J., & Kwatra, S. G. (2023). The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.01.042
Vancouver
Parthasarathy V, Cravero K, Xu L, Deng J, Sun Z, Engle SM, et al. The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis. Journal of the American Academy of Dermatology. 2023. doi:10.1016/j.jaad.2023.01.042
BibTeX
@article{Parthasarathy2023,
author = {Parthasarathy, Varsha and Cravero, Karen and Xu, Lillian and Deng, Junwen and Sun, Zhe and Engle, Sarah M and Sims, Jonathan T and Okragly, Angela J and Kwatra, Shawn G},
title = {The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis},
journal = {Journal of the American Academy of Dermatology},
year = {2023},
doi = {10.1016/j.jaad.2023.01.042}
}
EUVIMED